Metformin enhances radiation response of ECa109 cells through activation of ATM and AMPK.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2015-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biopha.2014.11.021PMID 25661368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• A Novel ATM/TP53/p21-Mediated Checkpoint Only Activated by Chronic γ-Irradiation

  2014cited by this paper
• Meta‐analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro‐oesophageal junctional cancers

  2014cited by this paper
• Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression

  2014cited by this paper
• Definitive chemoradiotherapy for oesophageal cancer -- a promising start on an exciting journey.

  2014cited by this paper
• Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines.

  2014cited by this paper
• Targeting glucose metabolism in patients with cancer

  2014cited by this paper
• Molecular Responses to Hypoxia-Inducible Factor 1α and Beyond

  2014cited by this paper
• Systematic Reviews and Meta- and Pooled Analyses Reduced Risk of Lung Cancer With Metformin Therapy in Diabetic Patients: A Systematic Review and Meta-Analysis

  2014cited by this paper
• STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α

  2014cited by this paper
• Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer

  2014cited by this paper
• Cucurbitacin B Induced ATM-Mediated DNA Damage Causes G2/M Cell Cycle Arrest in a ROS-Dependent Manner

  2014cited by this paper
• Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells

  2014cited by this paper
• Radiosensitization of Pancreatic Cancer Cells by Metformin through the AMPK Pathway

  2014cited by this paper
• Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK

  2013cited by this paper
• Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells.

  2013cited by this paper
• Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration

  2013cited by this paper
• Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo

  2013cited by this paper
• Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2–mediated suppression of mTORC1

  2013cited by this paper
• AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo.

  2013cited by this paper
• Molecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells.

  2013cited by this paper
• AMP-activated protein kinase: a target for old drugs against diabetes and cancer.

  2013cited by this paper
• Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival.

  2012cited by this paper
• Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells

  2012cited by this paper
• Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy

  2012cited by this paper
• Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

  2012cited by this paper
• The AMPK/SNF1/SnRK1 fuel gauge and energy regulator: structure, function and regulation

  2011cited by this paper
• Metformin activates an Ataxia Telangiectasia Mutated (ATM)/Chk2-regulated DNA damage-like response

  2011cited by this paper
• Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.

  2010cited by this paper
• Involvement of DNA-PK and ATM in radiation- and heat-induced DNA damage recognition and apoptotic cell death.

  2010cited by this paper
• AMPK in Health and Disease.

  2009cited by this paper
• mTOR signaling: implications for cancer and anticancer therapy.

  2007cited by this paper
• Metformin and reduced risk of cancer in diabetic patients

  2005cited by this paper
• mTOR signaling: implications for cancer and anticancer therapy

  2005cited by this paper
• Definitive chemoradiation in patients with inoperable oesophageal carcinoma

  2004cited by this paper
• Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.

  2003cited by this paper
• ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage.

  2002cited by this paper
• Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01)

  1999cited by this paper
• Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

  1999cited by this paper
• Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

  1998cited by this paper
• Enhanced phosphorylation of p53 by ATM in response to DNA damage.

  1998cited by this paper
• Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis.

  1998cited by this paper

• Atovaquone-induced activation of the PERK/eIF2α signaling axis mitigates metabolic radiosensitisation

  2025cites this paper
• Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer

  2024cites this paper
• Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights

  2024cites this paper
• Exploring the role and application of mitochondria in radiation therapy.

  2024cites this paper
• Radiosensitising Effects of Metformin Added to Concomitant Chemoradiotherapy with Cisplatin in Cervical Cancer.

  2023cites this paper
• Recent Insights of Metformin on Hepatocellular Carcinoma (HCC).

  2022cites this paper
• Linking Serine/Glycine Metabolism to Radiotherapy Resistance

  2021cites this paper
• The conductors of the metabolic orchestra

  2021cites this paper
• Proteomic signatures of radioresistance: Alteration of inflammation, angiogenesis and metabolism-related factors in radioresistant oesophageal adenocarcinoma.

  2021cites this paper
• Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer

  2020cites this paper
• Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response

  2020cites this paper
• Genome-Protecting Compounds as Potential Geroprotectors

  2020cites this paper
• Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers

  2020cites this paper
• Metformin: (future) best friend of the radiation oncologist?

  2020cites this paper
• An alcohol-soluble polysaccharide from Atractylodes macrocephala Koidz induces apoptosis of Eca-109 cells.

  2019cites this paper
• Metformin induces TPC-1 cell apoptosis through endoplasmic reticulum stress-associated pathways in vitro and in vivo.

  2019cites this paper
• The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients

  2019cites this paper
• Enhancing treatment response to neo-adjuvant radiation therapy in oesophageal cancer using novel dual action drugs targeting tumour energy metabolism and angiogenesis

  2019cites this paper
• Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.

  2018cites this paper
• Metformin Protects Against Radiation-Induced Heart Injury and Attenuates the Upregulation of Dual Oxidase Genes Following Rat’s Chest Irradiation

  2018cites this paper
• Pharmacogenetics of Antidiabetic Drugs.

  2018cites this paper
• Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer.

  2018cites this paper
• Effects of Different Temperatures on the Chemical Structure and Antitumor Activities of Polysaccharides from Cordyceps militaris

  2018cites this paper
• Glucose Oncometabolism of Esophageal Cancer.

  2017cites this paper
• Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials

  2017cites this paper
• Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1

  2017cites this paper
• Bufalin enhances radiosensitivity of glioblastoma by suppressing mitochondrial function and DNA damage repair.

  2017cites this paper
• Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I

  2017cites this paper
• Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer

  2016cites this paper
• Metformin enhances the radiosensitivity of human liver cancer cells to γ–rays and carbon ion beams

  2016cites this paper